Green quantitative spectrofluorometric analysis of rupatadine and montelukast at nanogram scale using direct and synchronous techniques

• Published in: Royal Society open science Vol. 8; no. 11; p. 211196
• Main Authors: Ghonim, Rana, El-Awady, Mohamed I, Tolba, Manar M, Ibrahim, Fawzia
• Format: Journal Article
• Language: English
• Published: England The Royal Society 01.11.2021
• Subjects: Chemistry; derivative synchronous fluorescence spectroscopy; montelukast; native fluorescence; pharmaceutical dosage forms; rupatadine; pharmaceutical dosage forms; montelukast; derivative synchronous fluorescence spectroscopy; native fluorescence; rupatadine
• ISSN: 2054-5703; 2054-5703
• DOI: 10.1098/rsos.211196

Two green-sensitive spectrofluorometric methods were investigated for assay of rupatadine (RUP) [method I] and its binary mixture with montelukast (MKT) [method II]. Method I depends on measuring native fluorescence of RUP in the presence of 0.10 M H SO and 0.10%w/v sodium dodecyl sulfate at 455 nm after excitation at 277 nm. The range of the first method was 0.20-2.00 µg ml with detection and quantitation limits of 59.00 and 179.00 ng ml , respectively. Method II depends on the first derivative synchronous spectrofluorometry. The derivative intensities were measured for the two drugs in an aqueous solution containing Mcllvaine's buffer pH 2.60 at fixed Δ of 140 nm. Each drug was estimated at zero-contribution of the other. The intensity was measured at 261 and 371 nm for RUP and MKT, respectively. The method was linear over 0.10-4.00 and 0.20-1.60 µg ml with limits of detection 31.00 and 66.00 ng ml and limits of quantitation 94.00 and 200.00 ng ml for RUP and MKT, respectively. The method was extended to determine this mixture in laboratory-prepared mixtures and combined tablets. Method validation was performed according to ICH guidelines. Statistical interpretation of data revealed good agreement with the comparison method. Method greenness was confirmed by applying three different assessment tools.